Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
FDA to pull common but ineffective cold medicine from market
The Food and Drug Administration announced Wednesday that it would seek to pull a widely used ingredient in cough and cold medicines from the market, after the agency's scientists concluded that the oral version of the drug is ineffective as a nasal decongestant.
FDA proposes removing ineffective decongestant found in most cold medicine
The Food and Drug Administration (FDA) is proposing the removal from the market of a common ingredient found in most oral over-the-counter cold medicines because it doesn’t work.
U.S. FDA proposes ending use of popular decongestant present in cold medicines
(Reuters) -The U.S. Food and Drug Administration has proposed to remove oral phenylephrine, widely used in cold and cough syrups, as an active ingredient in over-the-counter drugs for nasal congestion,
FDA Proposes Ban on a 'Useless' Decongestant, Phenylephrine
More than a year after its advisory panel unanimously declared the drug phenylephrine to be useless against nasal congestion, the U.S. Food and Drug Administration is proposing that it be removed from common over-the-counter decongestants.
13d
Myrtle Beach's Market Common will add townhomes and a coffee shop. Not everyone is happy about it.
Despite neighbors' objections, a drive-thru coffee shop, rental townhomes and cottages got the go-ahead to be built in Myrtle ...
13h
Luxury Estate Built on Site of Infamous 'Mansion Murders' Property Hits the Market for $8.5 Million—9 Years After Horrifying Killings
An incredibly modern mansion that was built on the site of the infamous "Mansion Murders" home has hit the market for $8.5 ...
Hosted on MSN
3h
These Over-The-Counter Decongestants Don't Work, FDA Says
A common ingredient found in most oral over-the-counter cold medicines should be removed from the market because it doesn’t ...
1d
Sonnet BioTherapeutics Announces Pricing of $5.0 Million Underwritten Public Offering Priced At-The-Market Under Nasdaq Rules
Sonnet BioTherapeutics Holdings, Inc. (the "Company" or "Sonnet”) (NASDAQ: SONN), a clinical-stage company developing ...
Mises Institute
11h
The Limits to Public Opinion and the Failure of Democracy
The question of restricting democracy came up because people tend to vote in ways that are contrary to their own interests in ...
2d
‘Kia Sorento… Probably the worst motors ever made’: Expert reveals the 5 worst mid-size SUVs that will cost you tons in repairs
TikTok creator Bev (@bevurly) is out to save people from what he calls “junk” vehicles. In one of his latest TikTok videos, ...
Traders Magazine
23h
Who Pays for Innovation? Why Market Collaboration is the Key to More Connectivity
The market needs more agility and connectivity to manage greater volumes and demands. But the question of who takes ownership for this innovation – and bears the cost – is more complex. With more ...
12d
The Election 2024 Playbook
Potential outcomes for the S&P500 post-election, include relief rally or crash scenarios due to election uncertainty and ...
1d
Mortgage-backed securities: How they impact the housing market and interest rates
Mortgage-backed securities (MBS) are a type of investment. Learn more about what MBS are, as well as how they impact the ...
9d
New Antibiotic Hits the Market to Tackle Stubborn UTIs
The Food and Drug Administration has approved Iterum Therapeutics' Orlynvah, the first drug of its kind, which is designed to ...
4d
The Stock Market Is Doing Something It Hasn't Done in Over a Half-Century, and It Could Signal a Big Move in 2025
In September, the Fed made its first interest rate cut since 2020, and it could be the start of a long cutting cycle over the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback